Page 669

(5) Burkholderia pseudomallei;

(6) Campylobacter species;

(7) Clostridium botulinum; the laboratory shall provide a sample of the organism and, if available, a serum, stool, emesis, food, or environmental sample;

(8) Clostridium tetani;

(9) Corynebacterium diphthriae;

(10) Escherichia coli, shiga toxin-producing;

(11) Francisella tularensis;

(12) Haemophillis ducreyi;

(13) Haemophilus influenzae from normally sterile body fluid or site;

(14) Listeria monocytogenes;

(15) Mycobacterium leprae;

(16) Mycobacterium tuberculosis;

(17) Neisseria gonorrhoeae;

(18) Neisseria meningitidis from normally sterile body fluid or site;

(19) Salmonella species;

(20) Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), suspected novel strains;

(21) Shigella species;

(22) Streptococcus agalactiae from normally sterile body fluid or site;

(23) Streptococcus pneumoniae from normally sterile body fluid or site;

(24) Streptococcus pyogenes from normally sterile body fluid or site;

(25) Vibrio species;

(26) Yersinia species. (f) Upon the request of the division of the department that oversees public health, a laboratory shall submit clinical material related to an outbreak or other unusual disease not identified in this section. (Eff. 8/21/74, Register 51; am 9/20/75, Register 55; am 3/28/84, Register 89; am 1/19/96, Register 137; am 2/10/99, Register 149; am 5/30/2003, Register 166; am 8/22/2003, Register